A recent study of 63 men receiving carbon ion radiotherapy for prostate cancer found similar RFs relating to Grey Level Zones were able to both predict the tumour metabolomics, such as alteration in the methionine amplitude and BCR. The gene discussed is BCR; the disease is prostate cancer.